Therapeutic Area Market Reports

Find the information you need on specific therapeutic markets. The Kalorama Information collection of research reports provides insights into new product trends, analyses, opportunities, projections, and marketing strategies. Specifics on market share, segmentation, size, and growth in US and global therapeutic markets are also featured. You’ll find the latest information regarding cancer, orthopedics, respiratory illness, dermatology, gastrointestinal, pediatric drugs, and more.

<< back 1 2 3 4 5 6 next >>

Title	Published	Price
Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis, 3rd Edition It is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products. Several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. M-Vax, Ocon-Vax in  |  more... Search inside this report	Nov 1, 2008	$3,995.00
Facial Rejuvenation Markets Worldwide The aging of the population, namely the baby boomer demographic segment is driving the market for facial rejuvenation products. The size and wealth of this aging segment and its overwhelming desire to retain a youthful appearance are driving growth for aesthetic procedures. Worldwide, billions of dollars are spent annually  |  more... Search inside this report	Aug 1, 2008	$3,500.00
The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends) Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments.  |  more...	Aug 1, 2008	$2,995.00
Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing: A Roadmap to Diagnostics in the 21st Century Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the  |  more... Search inside this report	Aug 1, 2008	$3,500.00
Major World Markets for Stents and The Economics of Drug-Eluting Technology Since the arrival of drug-eluting (called drug-eluding by some) technology a few years ago with the promise of reducing restenosis, questions abound surrounding the future of the stent market: After numerous clinical studies and mixed cost-effectiveness results, how is drug-eluding technology expected to peform in the future? What  |  more... Search inside this report	May 1, 2008	$2,800.00
Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2007 and 2008. Since Kalorama Information last updated Kalorama Information's The World Market for Vaccines in the first quarter of last year, new products and better than expected profits have transformed  |  more...	Apr 1, 2008	$4,100.00
The Worldwide Market for Cancer Diagnostics, 3rd Edition Who are the major players in testing for the number two killer in the world? What revenues can companies competing in this market expect in the next five years? How will the impact of trends such as an increased role of pharmacodiagnostics , the use of multiplex assays and  |  more...	Mar 1, 2008	$3,995.00
Congestive Heart Failure: Major World Markets, Volume I: Pharmaceutical Management Congestive heart failure is an increasingly important cause of cardiovascular morbidity and mortality. It is the number one cause of hospitalization among individuals aged 65 and over. The United States Medicare system pays out more for the care of congestive heart failure than it does for all forms of  |  more... Search inside this report	Feb 1, 2008	$3,495.00
Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets) Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients have developed dilated cardiomyopathy,  |  more...	Feb 1, 2008	$3,495.00
Pediatric Drugs: the Worldwide Market, 3rd Edition Although much of medicine is focused on the increased aging of the population, children still represent the bulk the dependent population worldwide. Important regulatory factors are at work in the pediatric pharmaceutical market. The recognition of the rights of children to have access to safe and effective  |  more...	Jan 1, 2008	$3,995.00
Worldwide Market for Rheumatoid Arthritis and Lupus Treatments ( Autoimmune Disease Markets ) Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. Additionally, autoimmune diseases are accounting for a growing  |  more... Search inside this report	Jan 1, 2008	$3,500.00
Prescription Dermatological Drugs: Worldwide Market, 6th Edition One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth time Kalorama Information has comprehensively studied the  |  more... Search inside this report	Jan 1, 2008	$4,200.00
The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents) Kalorama's 2nd edition of The World Cardiovascular Drugs Market , in its 2nd edition, will steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments. Analyst Mary  |  more... Search inside this report	Dec 1, 2007	$3,995.00
Anesthesia Drugs: Worldwide Markets An understanding of the market for anesthesia could be worthwhile to any pharmaceutical marketer and any equity company investing or consulting in this area. Anesthesia markets are in one sense simple: growth in these drugs are correlated to prevalence and incidence in disease, and the resulting increase in procedure  |  more... Search inside this report	Jul 1, 2007	$2,995.00
Global Tuberculosis Diagnostics and Treatment Markets The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated. Though nearly extinct in the 20th century, over 1.6 billion people worldwide suffer from tuberculosis, and it is now presenting a major crisis in public health circles. As illustrated by Kenneth G.  |  more... Search inside this report	Jun 1, 2007	$3,995.00
Multiple Sclerosis Treatments: World Market Outlook to 2011 Multiple sclerosis (MS) is a chronic demyelinating CNS disease that causes significant disability in young adults and others. Worldwide, millions of people are affected by multiple sclerosis. Although there is no cure, approved treatments are available to slow the progression of MS and offer improved quality of life.  |  more... Search inside this report	Jun 1, 2007	$2,995.00
Anti-Infectives: World Market, 2nd Edition, Vol III: Antivirals This third volume of Kalorama Information’s World Market for Anti-Infectives series, the 2nd. Edition focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease Inhibitors Other Misc. Antivirals The report covers both currently marketed and late stage development antiviral products in detail. For each  |  more... Search inside this report	May 1, 2007	$2,995.00
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and  |  more...	May 1, 2007	$1,995.00
Anti-Infectives: World Markets, 2nd Edition, Vol. I-III (Complete Series) This series provides total coverage of the Anti-Infectives market, a market that is changing due to product development resistance issues and in some cases, generic competition. Antifungals Antibacterials Antivirals As part of its comprehensive coverage, each report includes: Epidemiology including Incidence Statistics for each  |  more... Search inside this report	May 1, 2007	$5,995.00
Implant-Based Dental Reconstruction: The Worldwide Dental Implant and Bone Graft Market, 2nd Edition There is an important development occuring in the dental implant industry; one that opens up the procedure to new patients and provides new revenue opportunities. Dental implant systems are fast becoming the preferred restoration for replacement of missing  |  more... Buy by the section | Search inside this report	Apr 1, 2007	$3,995.00
Anti Infectives: World Market, 2nd Edition, Vol II: Antibacterials The market for antibiotics has changed and a knowledge of the current drug resistance situation is critical before operating in this marketplace. The effectiveness of many antibacterials (antibiotics) is being reduced as more and more types of bacteria become resistant to them. These and other developments  |  more...	Apr 1, 2007	$2,995.00
Smoking Cessation and Addiction Treatments: A World Market Analysis SMOKING CESSATION IS AN increasingly important area of focus for pharmaceutical companies, healthcare entities and governments. There are 1.4 billion smokers in the world, and smoking is a known cause of heart disease, lung cancer, respiratory infections and many other diseases. This has created a large market for smoking  |  more... Search inside this report	Apr 1, 2007	$2,995.00
Drug Delivery Markets, Vol III: Pulmonary Delivery Systems The lungs are considered by many to be the best alternative for drugs needing to bypass the gastrointestinal tract. With advancing technology, the practice of utilizing the huge surface area of the lungs to delivery drugs into the blood circulation has been slowly transforming into reality. The pulmonary drug  |  more...	Mar 1, 2007	$2,495.00
Refractive Vision Correction: A Market Analysis Since the advent of LASIK nearly two decades ago, refractive vision correction remains a vibrant market impacted by technology. Kalorama's market analysis takes a look at the entire market for non-disease eye treatment procedures. Complete coverage of the vision correction market, including the correction of conditions such as  |  more...	Mar 1, 2007	$1,495.00
Diabetes: Major World Markets, 3rd Ed. (Diagnostic and Treatment Markets in the US, Germany, Italy, Japan, Spain, UK and France) The market for diabetes-related products is huge and continuing to grow. However, it is not the same market as it was just 3 years ago. New trends in care, new products (both therapeutic and diagnostic), new approaches to long-term complications, and changing public health priorities along with geographic variations are  |  more... Buy by the section | Search inside this report	Mar 1, 2007	$3,995.00
Title	Published	Price

<< back 1 2 3 4 5 6 next >>